Feb 19, 2019
Discover the latest publication of Lallemand Pharma: « the fascinating world of bacteria: pharmaceutical and cosmetic applications » in the International Biopharmaceutical Industry journal.
Bacterial lysates were introduced in the 1970s, and were mainly used as immunostimulant drugs against infections. They are mixtures of inactivated, killed bacteria; in pharma applications the bacteria are pathogenic, and the principle is to trigger the immune defences thanks to their antigenic properties. Bacterial lysates allow the development of specific mucosal immunity to prevent and help fighting infections.
This article has been published in the Volume 1 Issue 3 2018 of the IBI journal :